Neurocrine Biosciences Announces Conference Call and Webcast to Present Second
Quarter 2004 Financial Results and Company Update
Quarter 2004 Financial Results and Company Update
SAN DIEGO, July 19 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report second quarter 2004 financial results after the Nasdaq market closes Wednesday, July 28, 2004. Neurocrine will also host a live conference call and Webcast to discuss its second quarter financial results and Company update Thursday morning, July 29, 2004 at 11:00 AM Eastern Daylight Time (EDT) / 8:00 AM Pacific Daylight Time (PDT). Participants may access the live Conference Call by dialing 1-800-540-0559 (U.S.) or 785-832-1508 (International) providing the Conference ID#: NBIX. The call can also be accessed via the Webcast through the Company's website at http://www.neurocrine.com or alternatively at PR Newswire: http://www.firstcallevents.com/service/ajwz408821053gf12.html.
Members from Neurocrine's senior management team will present the Company's second quarter 2004 financial results and provide an update on the Company's research and development programs. If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Jones or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-800-934-8425 (US) or 402-220-6995 (International) and will be archived until Thursday, August 12, 2004.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.
SOURCE Neurocrine Biosciences, Inc.